MARKET

PSNL

PSNL

Personalis
NASDAQ
10.48
+0.31
+3.05%
Pre Market: 10.42 -0.06 -0.57% 04:43 12/05 EST
OPEN
10.09
PREV CLOSE
10.17
HIGH
10.50
LOW
9.86
VOLUME
71
TURNOVER
0
52 WEEK HIGH
11.40
52 WEEK LOW
2.826
MARKET CAP
930.67M
P/E (TTM)
-11.9607
1D
5D
1M
3M
1Y
5Y
1D
Personalis assumed with an Equal Weight at Morgan Stanley
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Dyadic International (DYAI) and NeurAxis, Inc. (NRXS)
TipRanks · 3d ago
Weekly Report: what happened at PSNL last week (1124-1128)?
Weekly Report · 4d ago
Personalis Announces $100M Stock Offering Amendment
TipRanks · 6d ago
Personalis CFO and COO Aaron Tachibana Reports Disposal of Common Shares
Reuters · 6d ago
Personalis: A Growth Inflection Is Imminent, Hold
Seeking Alpha · 11/28 03:34
Personalis (PSNL) Gets a Buy from Lake Street
TipRanks · 11/25 13:55
Personalis Sees Revised Reimbursement Rates for Cancer Tests
TipRanks · 11/25 11:27
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.